Evaluation of antimicrobial susceptibility of clinical isolates of Salmonella


Sumerkan B., Inan M., Caglayangil A., AYGEN B., DOĞANAY M.

Mikrobiyoloji Bulteni, vol.28, no.1, pp.21-26, 1994 (Peer-Reviewed Journal) identifier

  • Publication Type: Article / Article
  • Volume: 28 Issue: 1
  • Publication Date: 1994
  • Journal Name: Mikrobiyoloji Bulteni
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.21-26

Abstract

Antimicrobial susceptibility of 111 clinical isolates of Salmonella was tested against 22 antimicrobials with disk diffusion method. Those were 4 quinolones, 4 aminoglycosides, 8 cephalosporins, ampicillin, chloramphenicol, ampicillin-sulbactam, anoxicillin-clavulanic acid, cefoperazone-sulbactam and trimethoprim-sulfamethoxazole (TMP-SMZ). Sixty-six (59%) of 111 isolates were identified in group B Salmonella. Fifty (76%) of 66 isolates in group B were found to be resistant to ampicillin, 44 (67%) to TMP-SMZ and 42 (64%) to chloramphenicol. No resistance was observed in 35 isolates of S. typhi to chloramphenicol. All isolates of Salmonella were susceptible to amikacin and quinolones. Fourty (60%) of 66 isolates in group B were multiple resistant to ampicillin, TMP-SMZ and chloramphenicol. No multiresistance was observed in the isolates of S. typhi.